Thank you for your interest in participating in a TaperMD Beta trial.
We have limited spots available for Phase 1, but we then plan to rapidly expand to Phase 2 in a few months. For Phase 1 we are prioritizing testers in the following groups:
- Primary care physicians and nurse practitioners.
- Long-term care facilities.
- Payers (government, insurance companies, corporations).
- Pharmacy chains.
- Patient advocate groups.
We will be back to you within a few weeks on whether we can slot you into Phase 1 or 2.
In the meantime, we have sent you a confirmation email with a link to download our Pause and Monitor white paper.